{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:50:21Z","timestamp":1792785021026,"version":"4.5.0"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,11]],"date-time":"2025-07-11T00:00:00Z","timestamp":1752192000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,7,11]],"date-time":"2025-07-11T00:00:00Z","timestamp":1752192000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82074378"],"award-info":[{"award-number":["82074378"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100019971","name":"Luzhou Science and Technology Bureau","doi-asserted-by":"publisher","award":["2023JYJ029"],"award-info":[{"award-number":["2023JYJ029"]}],"id":[{"id":"10.13039\/501100019971","id-type":"DOI","asserted-by":"publisher"}]},{"name":"2024 Traditional Chinese Medicine Guangdong Provincial Laboratory Project","award":["HQCML-C-2024005"],"award-info":[{"award-number":["HQCML-C-2024005"]}]},{"name":"Shenzhen Science and Technology Program","award":["JCYJ20230807094603007"],"award-info":[{"award-number":["JCYJ20230807094603007"]}]},{"name":"Shenzhen Medical Research Fund","award":["A2403028"],"award-info":[{"award-number":["A2403028"]}]},{"DOI":"10.13039\/501100010706","name":"Luzhou Medical College","doi-asserted-by":"publisher","award":["2023ZYYQ04"],"award-info":[{"award-number":["2023ZYYQ04"]}],"id":[{"id":"10.13039\/501100010706","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-10631-9","type":"journal-article","created":{"date-parts":[[2025,7,11]],"date-time":"2025-07-11T17:53:34Z","timestamp":1752256414000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Zhilong Huoxue Tongyu capsule inhibits hypertensive myocardial fibrosis via balancing TGF-\u03b21\/Smad3\/Erbb4-IR\/miR-29b pathway"],"prefix":"10.1038","volume":"15","author":[{"given":"Qiuyu","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dingshan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raoqiong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shihan","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanyuan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenxun","family":"Wan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yumei","family":"Qian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinrui","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gang","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingtai","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengnan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,11]]},"reference":[{"key":"10631_CR1","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1038\/s41569-018-0119-4","volume":"16","author":"D Zhao","year":"2019","unstructured":"Zhao, D., Liu, J., Wang, M., Zhang, X. & Zhou, M. Epidemiology of cardiovascular disease in china: current features and implications. Nat. Rev. Cardiol. 16, 203\u2013212 (2019).","journal-title":"Nat. Rev. Cardiol."},{"key":"10631_CR2","doi-asserted-by":"publisher","first-page":"110066","DOI":"10.1016\/j.cellsig.2021.110066","volume":"85","author":"MP Czubryt","year":"2021","unstructured":"Czubryt, M. P. & Hale, T. M. Cardiac fibrosis: pathobiology and therapeutic targets. Cell. Signal. 85, 110066 (2021).","journal-title":"Cell. Signal."},{"key":"10631_CR3","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1038\/s41569-020-00504-1","volume":"18","author":"B L\u00f3pez","year":"2021","unstructured":"L\u00f3pez, B. et al. Diffuse myocardial fibrosis: mechanisms, diagnosis and therapeutic approaches. Nat. Rev. Cardiol. 18, 479\u2013498 (2021).","journal-title":"Nat. Rev. Cardiol."},{"key":"10631_CR4","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.yjmcc.2017.07.011","volume":"110","author":"Y Guo","year":"2017","unstructured":"Guo, Y. et al. Entanglement of GSK-3\u03b2, \u03b2-catenin and TGF-\u03b21 signaling network to regulate myocardial fibrosis. J. Mol. Cell. Cardiol. 110, 109\u2013120 (2017).","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10631_CR5","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1097\/HJH.0000000000001258","volume":"35","author":"S Ravassa","year":"2017","unstructured":"Ravassa, S. et al. Phenotyping of myocardial fibrosis in hypertensive patients with heart failure. Influence on clinical outcome. J. Hypertens. 35, 853\u2013861 (2017).","journal-title":"J. Hypertens."},{"key":"10631_CR6","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1007\/s10741-016-9536-9","volume":"21","author":"A Piek","year":"2016","unstructured":"Piek, A., de Boer, R. A. & Sillj\u00e9, H. H. W. The fibrosis-cell death axis in heart failure. Heart Fail. Rev. 21, 199\u2013211 (2016).","journal-title":"Heart Fail. Rev."},{"key":"10631_CR7","doi-asserted-by":"publisher","first-page":"106515","DOI":"10.1016\/j.phrs.2022.106515","volume":"185","author":"M Liu","year":"2022","unstructured":"Liu, M. et al. Hypertensive heart disease and myocardial fibrosis: how traditional Chinese medicine can help addressing unmet therapeutical needs. Pharmacol. Res. 185, 106515 (2022).","journal-title":"Pharmacol. Res."},{"key":"10631_CR8","doi-asserted-by":"publisher","first-page":"1248468","DOI":"10.3389\/fcvm.2023.1248468","volume":"10","author":"V Lee","year":"2023","unstructured":"Lee, V. et al. Sacubitril\/valsartan versus Valsartan in regressing myocardial fibrosis in hypertension: a prospective, randomized, open-label, blinded endpoint clinical trial protocol. Front. Cardiovasc. Med. 10, 1248468 (2023).","journal-title":"Front. Cardiovasc. Med."},{"key":"10631_CR9","doi-asserted-by":"publisher","first-page":"154013","DOI":"10.1016\/j.metabol.2019.154013","volume":"103","author":"BH Xu","year":"2020","unstructured":"Xu, B. H. et al. Deletion of Smad3 prevents renal fibrosis and inflammation in type 2 diabetic nephropathy. Metabolism 103, 154013 (2020).","journal-title":"Metabolism"},{"key":"10631_CR10","doi-asserted-by":"publisher","first-page":"e53573","DOI":"10.1371\/journal.pone.0053573","volume":"8","author":"GX Liu","year":"2013","unstructured":"Liu, G. X. et al. Disruption of Smad7 promotes ANG II-mediated renal inflammation and fibrosis via Sp1-TGF-\u03b2\/Smad3-NF.\u03baB-dependent mechanisms in mice. PLoS One. 8, e53573 (2013).","journal-title":"PLoS One"},{"key":"10631_CR11","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1038\/s41576-023-00662-1","volume":"25","author":"K Nemeth","year":"2024","unstructured":"Nemeth, K., Bayraktar, R., Ferracin, M. & Calin, G. A. Non-coding RNAs in disease: from mechanisms to therapeutics. Nat. Rev. Genet. 25, 211\u2013232 (2024).","journal-title":"Nat. Rev. Genet."},{"key":"10631_CR12","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.ymthe.2017.09.024","volume":"26","author":"M Feng","year":"2018","unstructured":"Feng, M. et al. TGF-\u03b2 mediates renal fibrosis via the Smad3-Erbb4-IR long noncoding RNA Axis. Mol. Ther. 26, 148\u2013161 (2018).","journal-title":"Mol. Ther."},{"key":"10631_CR13","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1016\/j.ajpath.2013.10.007","volume":"184","author":"Q Zhou","year":"2014","unstructured":"Zhou, Q. et al. Identification of novel long noncoding RNAs associated with TGF-\u03b2\/Smad3-mediated renal inflammation and fibrosis by RNA sequencing. Am. J. Pathol. 184, 409\u2013417 (2014).","journal-title":"Am. J. Pathol."},{"key":"10631_CR14","doi-asserted-by":"publisher","first-page":"1485","DOI":"10.2337\/db18-1075","volume":"68","author":"YY Zhang","year":"2019","unstructured":"Zhang, Y. Y. et al. LRNA9884, a novel Smad3-Dependent long noncoding RNA, promotes diabetic kidney injury in db\/db mice via enhancing MCP-1-Dependent renal inflammation. Diabetes 68, 1485\u20131498 (2019).","journal-title":"Diabetes"},{"key":"10631_CR15","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1016\/j.omtn.2023.06.017","volume":"33","author":"JC Li","year":"2023","unstructured":"Li, J. C. et al. Angiotensin II mediates hypertensive cardiac fibrosis via an Erbb4-IR-dependent mechanism. Mol. Therapy - Nucleic Acids. 33, 180\u2013190 (2023).","journal-title":"Mol. Therapy - Nucleic Acids"},{"key":"10631_CR16","first-page":"70","volume":"38","author":"M Liu","year":"2022","unstructured":"Liu, M. et al. Zhilong Huoxue Tongyu capsule down regulates Erbb4-IR and inhibits cardiac fibroblast fibrosis in mice via TGFB1\/SMAD3 signaling pathway. Pharmacol. Clin. Chin. Materia Med. 38, 70\u201375 (2022).","journal-title":"Pharmacol. Clin. Chin. Materia Med."},{"key":"10631_CR17","first-page":"50","volume":"26","author":"JY Chen","year":"2019","unstructured":"Chen, J. Y. Guizhi Decoction and Guishao in different proportions regulate TGF-\u03b21\/Smads signal pathway and chronic inflammation improve myocardial fibrosis in salt-sensitive hypertensive rats. Chin. J. Experimental Prescriptions. 26, 50\u201358 (2019).","journal-title":"Chin. J. Experimental Prescriptions"},{"key":"10631_CR18","first-page":"173","volume":"24","author":"J Wang","year":"2018","unstructured":"Wang, J., Li, F., Zhou, X. L. & Zeng, Q. N. Clinical observation on the treatment of myocardial fibrosis in chronic heart failure with modified Zhenwu Decoction. Chin. J. Experimental Prescriptions. 24, 173\u2013178 (2018).","journal-title":"Chin. J. Experimental Prescriptions"},{"key":"10631_CR19","doi-asserted-by":"publisher","first-page":"e0302650","DOI":"10.1371\/journal.pone.0302650","volume":"19","author":"X Zhao","year":"2024","unstructured":"Zhao, X. et al. Zhilong Huoxue Tongyu capsule improves myocardial ischemia\/reperfusion injury via the PI3K\/AKT\/Nrf2 axis. PLoS One. 19, e0302650 (2024).","journal-title":"PLoS One"},{"key":"10631_CR20","doi-asserted-by":"crossref","unstructured":"Liu, M. et al. Zhilong Huoxue Tongyu Capsule Alleviated the Pyroptosis of Vascular Endothelial Cells Induced by ox-LDL through miR-30b-5p\/NLRP3, Evid Based Complement Alternat Med. 3981350 (2022). (2022).","DOI":"10.1155\/2022\/3981350"},{"key":"10631_CR21","doi-asserted-by":"publisher","first-page":"1269","DOI":"10.1161\/CIRCRESAHA.116.305381","volume":"116","author":"A Leask","year":"2015","unstructured":"Leask, A. Getting to the heart of the matter: new insights into cardiac fibrosis. Circ. Res. 116, 1269\u20131276 (2015).","journal-title":"Circ. Res."},{"key":"10631_CR22","doi-asserted-by":"publisher","first-page":"18014","DOI":"10.1038\/nrdp.2018.14","volume":"4","author":"S Oparil","year":"2018","unstructured":"Oparil, S. et al. Hypertension, Nat. Rev. Dis. Primers 4, 18014 (2018).","journal-title":"Nat. Rev. Dis. Primers"},{"key":"10631_CR23","doi-asserted-by":"publisher","first-page":"850060","DOI":"10.3389\/fphar.2022.850060","volume":"13","author":"M Mazhar","year":"2022","unstructured":"Mazhar, M. et al. Zhilong Huoxue Tongyu capsules ameliorate early brain inflammatory injury induced by intracerebral hemorrhage via Inhibition of canonical NF\u043a\u03b2 signalling pathway. Front. Pharmacol. 13, 850060 (2022).","journal-title":"Front. Pharmacol."},{"key":"10631_CR24","doi-asserted-by":"publisher","first-page":"e20026","DOI":"10.1016\/j.heliyon.2023.e20026","volume":"9","author":"M Liu","year":"2023","unstructured":"Liu, M. et al. Zhilong Huoxue Tongyu capsule inhibits rabbit model of hyperlipidemia and atherosclerosis through NF-\u03baB\/NLRP3 signaling pathway. Heliyon 9, e20026 (2023).","journal-title":"Heliyon"},{"key":"10631_CR25","doi-asserted-by":"publisher","first-page":"914518","DOI":"10.3389\/fphar.2022.914518","volume":"13","author":"M Liu","year":"2022","unstructured":"Liu, M. et al. Network Pharmacology and in vitro experimental verification reveal the mechanism of the Hirudin in suppressing myocardial hypertrophy. Front. Pharmacol. 13, 914518 (2022).","journal-title":"Front. Pharmacol."},{"key":"10631_CR26","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.addr.2019.05.011","volume":"146","author":"S Hinderer","year":"2019","unstructured":"Hinderer, S. & Schenke-Layland, K. Cardiac fibrosis - A short review of causes and therapeutic strategies. Adv. Drug Deliv. Rev. 146, 77\u201382 (2019).","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10631_CR27","doi-asserted-by":"publisher","first-page":"1824","DOI":"10.1016\/j.jacc.2017.01.048","volume":"69","author":"M Wysoczynski","year":"2017","unstructured":"Wysoczynski, M. et al. Myocardial reparative properties of cardiac mesenchymal cells isolated on the basis of adherence. J. Am. Coll. Cardiol. 69, 1824\u20131838 (2017).","journal-title":"J. Am. Coll. Cardiol."},{"key":"10631_CR28","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/s40824-016-0060-8","volume":"20","author":"Z Fan","year":"2016","unstructured":"Fan, Z. & Guan, J. Antifibrotic therapies to control cardiac fibrosis. Biomater. Res. 20, 13 (2016).","journal-title":"Biomater. Res."},{"key":"10631_CR29","doi-asserted-by":"publisher","first-page":"1761","DOI":"10.1016\/j.metabol.2013.08.010","volume":"62","author":"AT Whaley-Connell","year":"2013","unstructured":"Whaley-Connell, A. T. et al. Salt loading exacerbates diastolic dysfunction and cardiac remodeling in young female Ren2 rats. Metabolism 62, 1761\u20131771 (2013).","journal-title":"Metabolism"},{"key":"10631_CR30","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1016\/j.yjmcc.2010.10.033","volume":"51","author":"M Dobaczewski","year":"2011","unstructured":"Dobaczewski, M., Chen, W. & Frangogiannis, N. G. Transforming growth factor (TGF)-\u03b2 signaling in cardiac remodeling. J. Mol. Cell. Cardiol. 51, 600\u2013606 (2011).","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10631_CR31","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1016\/j.ultrasmedbio.2017.09.022","volume":"44","author":"Y Li","year":"2018","unstructured":"Li, Y. et al. Histologic and hemodynamic correlates of right ventricular function in a pressure overload model: a study using Three-Dimensional speckle tracking echocardiography. Ultrasound Med. Biol. 44, 467\u2013476 (2018).","journal-title":"Ultrasound Med. Biol."},{"key":"10631_CR32","doi-asserted-by":"publisher","first-page":"R710","DOI":"10.1152\/ajpregu.00159.2022","volume":"323","author":"JC Craig","year":"2022","unstructured":"Craig, J. C. et al. Impaired hemodynamic response to exercise in patients with peripheral artery disease: evidence of a link to inflammation and oxidative stress. Am. J. Physiol. Regul. Integr. Comp. Physiol. 323, R710\u2013R719 (2022).","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"key":"10631_CR33","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1053\/j.ajkd.2018.12.034","volume":"73","author":"Y Lytvyn","year":"2019","unstructured":"Lytvyn, Y. et al. Renal hemodynamic function and RAAS activation over the natural history of type 1 diabetes. Am. J. Kidney Dis. 73, 786\u2013796 (2019).","journal-title":"Am. J. Kidney Dis."},{"key":"10631_CR34","doi-asserted-by":"publisher","first-page":"722530","DOI":"10.3389\/fphar.2021.722530","volume":"12","author":"J Pan","year":"2021","unstructured":"Pan, J. et al. Huangqi shengmai Yin ameliorates myocardial fibrosis by activating Sirtuin3 and inhibiting TGF-\u03b2\/Smad pathway. Front. Pharmacol. 12, 722530 (2021).","journal-title":"Front. Pharmacol."},{"key":"10631_CR35","doi-asserted-by":"publisher","first-page":"974","DOI":"10.1038\/mt.2014.25","volume":"22","author":"Y Zhang","year":"2014","unstructured":"Zhang, Y. et al. miR-29b as a therapeutic agent for angiotensin II-induced cardiac fibrosis by targeting TGF-\u03b2\/Smad3 signaling. Mol. Ther. 22, 974\u2013985 (2014).","journal-title":"Mol. Ther."},{"key":"10631_CR36","doi-asserted-by":"publisher","first-page":"1251","DOI":"10.1038\/mt.2012.36","volume":"20","author":"J Xiao","year":"2012","unstructured":"Xiao, J. et al. miR-29 inhibits bleomycin-induced pulmonary fibrosis in mice. Mol. Ther. 20, 1251\u20131260 (2012).","journal-title":"Mol. Ther."},{"key":"10631_CR37","doi-asserted-by":"publisher","first-page":"1462","DOI":"10.1681\/ASN.2010121308","volume":"22","author":"W Qin","year":"2011","unstructured":"Qin, W. et al. TGF-\u03b2\/Smad3 signaling promotes renal fibrosis by inhibiting miR-29. J. Am. Soc. Nephrol. 22, 1462\u20131474 (2011).","journal-title":"J. Am. Soc. Nephrol."},{"key":"10631_CR38","doi-asserted-by":"publisher","first-page":"13767","DOI":"10.1080\/21655979.2022.2084253","volume":"13","author":"T Wang","year":"2022","unstructured":"Wang, T., Jiang, X., Ruan, Y., Zhuang, J. & Yin, Y. Based on network Pharmacology and in vitro experiments to prove the effective Inhibition of myocardial fibrosis by Buyang Huanwu Decoction. Bioengineered 13, 13767\u201313783 (2022).","journal-title":"Bioengineered"},{"key":"10631_CR39","doi-asserted-by":"publisher","first-page":"e007923","DOI":"10.1161\/CIRCOUTCOMES.121.007923","volume":"15","author":"X Lai","year":"2022","unstructured":"Lai, X. et al. Efficacy and safety of Chinese herbal medicine compared with Losartan for mild essential hypertension: A randomized, multicenter, Double-Blind, noninferiority trial. Circ. Cardiovasc. Qual. Outcomes. 15, e007923 (2022).","journal-title":"Circ. Cardiovasc. Qual. Outcomes"},{"key":"10631_CR40","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1111\/1440-1681.13042","volume":"46","author":"H Ding","year":"2019","unstructured":"Ding, H., Zhou, Y. & Huang, H. MiR-101a ameliorates AngII-mediated hypertensive nephropathy by Blockade of TGF\u03b2\/Smad3 and NF-\u03baB signalling in a mouse model of hypertension. Clin. Exp. Pharmacol. Physiol. 46, 246\u2013254 (2019).","journal-title":"Clin. Exp. Pharmacol. Physiol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-10631-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-10631-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-10631-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,7]],"date-time":"2025-09-07T05:57:53Z","timestamp":1757224673000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-10631-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,11]]},"references-count":40,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["10631"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-10631-9","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,11]]},"assertion":[{"value":"18 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no conflicts of interest, financial or otherwise.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"25127"}}